Wells Fargo
MGNX icon

Wells Fargo’s MacroGenics MGNX Stock Holding History

Wells Fargo’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.67K Hold
3,000
– – ﹤0.01% 5996
2025
Q4 		$4.83K Hold
3,000
– – ﹤0.01% 6103
2025
Q3 		$5.04K Buy
3,000
+2,482
+479% +$4.02K ﹤0.01% 6075
2025
Q2 		$627 Sell
518
-29,993
-98% -$43.5K ﹤0.01% 6354
2025
Q1 		$38.7K Buy
30,511
+673
+2% +$1.76K ﹤0.01% 5481
2024
Q4 		$97K Buy
29,838
+9,312
+45% +$33.5K ﹤0.01% 5218
2024
Q3 		$67.5K Sell
20,526
-450
-2% -$1.75K ﹤0.01% 5227
2024
Q2 		$89.1K Buy
20,976
+268
+1% +$2.61K ﹤0.01% 5000
2024
Q1 		$305K Buy
20,708
+2,662
+15% +$40.2K ﹤0.01% 4210
2023
Q4 		$174K Buy
18,046
+3,569
+25% +$24.7K ﹤0.01% 4545
2023
Q3 		$67.5K Sell
14,477
-9,509
-40% -$47.3K ﹤0.01% 5013
2023
Q2 		$128K Buy
23,986
+13,131
+121% +$81K ﹤0.01% 4875
2023
Q1 		$77.8K Buy
10,855
+10,671
+5,799% +$64.3K ﹤0.01% 4941
2022
Q4 		$1.24K Sell
184
-3,432
-95% -$18.8K ﹤0.01% 6124
2022
Q3 		$12K Sell
3,616
-620
-15% -$2.37K ﹤0.01% 5614
2022
Q2 		$12K Sell
4,236
-33,329
-89% -$175K ﹤0.01% 5672
2022
Q1 		$332K Sell
37,565
-19,594
-34% -$216K ﹤0.01% 4693
2021
Q4 		$917K Sell
57,159
-30,516
-35% -$574K ﹤0.01% 4179
2021
Q3 		$1.84M Sell
87,675
-16,583
-16% -$399K ﹤0.01% 3740
2021
Q2 		$2.8M Sell
104,258
-37,477
-26% -$1.1M ﹤0.01% 3396
2021
Q1 		$4.51M Buy
141,735
+8,992
+7% +$218K ﹤0.01% 2953
2020
Q4 		$3.03M Buy
132,743
+76,945
+138% +$1.77M ﹤0.01% 3176
2020
Q3 		$1.41M Buy
55,798
+3,949
+8% +$108K ﹤0.01% 3603
2020
Q2 		$1.45M Buy
51,849
+7,250
+16% +$126K ﹤0.01% 3532
2020
Q1 		$260K Sell
44,599
-26,950
-38% -$245K ﹤0.01% 4505
2019
Q4 		$779K Buy
71,549
+38,244
+115% +$379K ﹤0.01% 4030
2019
Q3 		$425K Buy
33,305
+9,089
+38% +$131K ﹤0.01% 4482
2019
Q2 		$411K Sell
24,216
-49,911
-67% -$857K ﹤0.01% 4512
2019
Q1 		$1.33M Sell
74,127
-16,454
-18% -$284K ﹤0.01% 3672
2018
Q4 		$1.15M Buy
90,581
+30,620
+51% +$514K ﹤0.01% 3727
2018
Q3 		$1.29M Buy
59,961
+1,568
+3% +$33.4K ﹤0.01% 3775
2018
Q2 		$1.21M Buy
58,393
+36,898
+172% +$831K ﹤0.01% 3859
2018
Q1 		$540K Buy
21,495
+1,391
+7% +$33.8K ﹤0.01% 4339
2017
Q4 		$383K Sell
20,104
-7,610
-27% -$142K ﹤0.01% 4579
2017
Q3 		$513K Buy
27,714
+2,862
+12% +$49.6K ﹤0.01% 4315
2017
Q2 		$435K Sell
24,852
-23,348
-48% -$445K ﹤0.01% 4307
2017
Q1 		$896K Buy
48,200
+24,198
+101% +$467K ﹤0.01% 3828
2016
Q4 		$490K Buy
24,002
+10,973
+84% +$276K ﹤0.01% 4215
2016
Q3 		$390K Buy
13,029
+3,858
+42% +$115K ﹤0.01% 4088
2016
Q2 		$248K Sell
9,171
-3,253
-26% -$73.4K ﹤0.01% 4284
2016
Q1 		$233K Buy
12,424
+2,764
+29% +$52.6K ﹤0.01% 4311
2015
Q4 		$299K Sell
9,660
-671
-6% -$20.4K ﹤0.01% 4218
2015
Q3 		$221K Sell
10,331
-36,561
-78% -$1.15M ﹤0.01% 4411
2015
Q2 		$1.78M Buy
46,892
+1,908
+4% +$62.7K ﹤0.01% 3171
2015
Q1 		$1.41M Buy
44,984
+25,557
+132% +$866K ﹤0.01% 3288
2014
Q4 		$682K Buy
19,427
+16,025
+471% +$399K ﹤0.01% 3754
2014
Q3 		$71K Sell
3,402
-249
-7% -$5.15K ﹤0.01% 4797
2014
Q2 		$80K Buy
3,651
+1,574
+76% +$33.1K ﹤0.01% 4770
2014
Q1 		$58K Buy
+2,077
New +$73.3K ﹤0.01% 4876

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wells Fargo's MGNX Position: Q1 2026 in Review

Wells Fargo held its MacroGenics (MGNX) position steady in Q1 2026 at 3,000 shares worth $8.67K. The position accounts for ﹤0.01% of the portfolio, ranked #5996.

Wells Fargo first reported a position in MGNX in Q1 2014 and has held it in 49 quarters since. The position peaked at $4.51M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Wells Fargo held 3,000 shares of MacroGenics worth $8.67K as of Q1 2026.
  • Wells Fargo left its MacroGenics share count unchanged in Q1 2026.
  • MacroGenics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5996 holding.
  • Wells Fargo first reported a position in MacroGenics in Q1 2014 and has held it in 49 quarters since.
  • Wells Fargo's MacroGenics position peaked at $4.51M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.